Xtant Medical Holdings, Inc. (XTNT)
NYSEAMERICAN: XTNT · Real-Time Price · USD
0.553
+0.024 (4.54%)
At close: Apr 28, 2026, 4:00 PM EDT
0.501
-0.052 (-9.39%)
After-hours: Apr 28, 2026, 8:00 PM EDT
Xtant Medical Holdings Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2020 - 2016 |
| Operating Revenue | 133.93 | 117.27 | 91.3 | 57.97 | 55.15 | Upgrade
|
| Other Revenue | - | - | - | - | 0.12 | Upgrade
|
| Revenue | 133.93 | 117.27 | 91.3 | 57.97 | 55.26 | Upgrade
|
| Revenue Growth (YoY) | 14.21% | 28.44% | 57.50% | 4.90% | 3.61% | Upgrade
|
| Cost of Revenue | 49.65 | 49.05 | 35.84 | 25.83 | 22.77 | Upgrade
|
| Gross Profit | 84.27 | 68.22 | 55.47 | 32.14 | 32.49 | Upgrade
|
| Selling, General & Admin | 74.89 | 77.91 | 64.29 | 37.98 | 34.87 | Upgrade
|
| Research & Development | 2.1 | 2.39 | 1.34 | 0.92 | 0.87 | Upgrade
|
| Operating Expenses | 76.99 | 80.29 | 65.63 | 38.89 | 35.74 | Upgrade
|
| Operating Income | 7.28 | -12.07 | -10.16 | -6.76 | -3.25 | Upgrade
|
| Interest Expense | -3.67 | -4.16 | -2.94 | -1.69 | -1 | Upgrade
|
| Interest & Investment Income | 0.09 | - | 0.15 | 0.03 | - | Upgrade
|
| Currency Exchange Gain (Loss) | -0.06 | 0.01 | 0.27 | - | - | Upgrade
|
| Other Non Operating Income (Expenses) | 0.07 | -0.03 | -0.05 | - | - | Upgrade
|
| EBT Excluding Unusual Items | 3.72 | -16.26 | -12.73 | -8.42 | -4.25 | Upgrade
|
| Gain (Loss) on Sale of Assets | 3.28 | - | - | - | - | Upgrade
|
| Legal Settlements | - | - | - | - | -0.6 | Upgrade
|
| Other Unusual Items | - | - | 11.69 | - | - | Upgrade
|
| Pretax Income | 7 | -16.26 | -1.04 | -8.42 | -4.85 | Upgrade
|
| Income Tax Expense | 2.03 | 0.19 | -1.7 | 0.07 | - | Upgrade
|
| Net Income | 4.97 | -16.45 | 0.66 | -8.49 | -4.85 | Upgrade
|
| Net Income to Common | 4.97 | -16.45 | 0.66 | -8.49 | -4.85 | Upgrade
|
| Shares Outstanding (Basic) | 140 | 134 | 119 | 94 | 85 | Upgrade
|
| Shares Outstanding (Diluted) | 150 | 134 | 127 | 94 | 85 | Upgrade
|
| Shares Change (YoY) | 12.25% | 5.42% | 34.76% | 10.10% | 199.85% | Upgrade
|
| EPS (Basic) | 0.04 | -0.12 | 0.01 | -0.09 | -0.06 | Upgrade
|
| EPS (Diluted) | 0.03 | -0.12 | 0.01 | -0.09 | -0.06 | Upgrade
|
| Free Cash Flow | 10.16 | -16.01 | -10.97 | -7.11 | -1.68 | Upgrade
|
| Free Cash Flow Per Share | 0.07 | -0.12 | -0.09 | -0.08 | -0.02 | Upgrade
|
| Gross Margin | 62.92% | 58.17% | 60.75% | 55.44% | 58.79% | Upgrade
|
| Operating Margin | 5.44% | -10.30% | -11.13% | -11.65% | -5.89% | Upgrade
|
| Profit Margin | 3.71% | -14.03% | 0.72% | -14.64% | -8.77% | Upgrade
|
| Free Cash Flow Margin | 7.59% | -13.65% | -12.02% | -12.26% | -3.03% | Upgrade
|
| EBITDA | 12.51 | -7.85 | -6.98 | -5.46 | -1.92 | Upgrade
|
| EBITDA Margin | 9.34% | -6.69% | -7.65% | -9.42% | -3.48% | Upgrade
|
| D&A For EBITDA | 5.22 | 4.22 | 3.17 | 1.29 | 1.33 | Upgrade
|
| EBIT | 7.28 | -12.07 | -10.16 | -6.76 | -3.25 | Upgrade
|
| EBIT Margin | 5.44% | -10.30% | -11.13% | -11.65% | -5.89% | Upgrade
|
| Effective Tax Rate | 28.97% | - | - | - | - | Upgrade
|
| Revenue as Reported | 133.93 | 117.27 | 91.3 | - | 55.26 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.